Evidence map›Paper›PMID 33483422›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Genome-wide CRISPR screens reveal multitiered mechanisms through which mTORC1 senses mitochondrial dysfunction.

Kendall J Condon, Jose M Orozco, Charles H Adelmann, Jessica B Spinelli, Pim W van der Helm, Justin M Roberts, Tenzin Kunchok, David M Sabatini

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
8.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 126 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Phenotypic CRISPR screens identify NLRX1 as an essential activator of the human mitochondrial permeability transition.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Review
  11. Review
  12. Article
  13. The adhesion GPCR ADGRL2 engages Gα13 to enable epidermal differentiation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kendall J CondonWhitehead Institute for Biomedical Research, Cambridge, MA 02142.
Jose M OrozcoWhitehead Institute for Biomedical Research, Cambridge, MA 02142.ORCID https://orcid.org/0000-0002-4587-0777
Charles H AdelmannWhitehead Institute for Biomedical Research, Cambridge, MA 02142.
Jessica B SpinelliWhitehead Institute for Biomedical Research, Cambridge, MA 02142.
Pim W van der HelmWhitehead Institute for Biomedical Research, Cambridge, MA 02142.ORCID https://orcid.org/0000-0002-4524-8240
Justin M RobertsWhitehead Institute for Biomedical Research, Cambridge, MA 02142.ORCID https://orcid.org/0000-0001-6112-7476
Tenzin KunchokWhitehead Institute for Biomedical Research, Cambridge, MA 02142.
David M SabatiniWhitehead Institute for Biomedical Research, Cambridge, MA 02142; sabatini@wi.mit.edu.ORCID https://orcid.org/0000-0002-1446-7256
Broad Institute · USWhitehead Institute for Biomedical Research · US

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
PRE-DOCTORAL TRAINING IN THE BIOLOGICAL SCIENCEST32GM007287 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BELL, STEPHEN P., KEATING, AMY E · 1985 to 2019
$40.8M
Regulation of the mTOR Pathway By NutrientsR01CA103866 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI WEISSMAN, JONATHAN S. · 2004 to 2021
$7.0M
Cell Growth Signaling in Cancer DevelopmentR01CA129105 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI WEISSMAN, JONATHAN S. · 2008 to 2021
$5.9M
TRANSLATIONAL CONTROL BY RAPAMYCIN-SENSITIVE SIGNALINGR01AI047389 · NIAID · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI WEISSMAN, JONATHAN S. · 2000 to 2021
$4.9M
Metabolic Recycling and Compartmentalization in Tumor ProgressionK00CA234839 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI SPINELLI, JESSICA BROOKE · 2019 to 2022
$394k
Defining the mechanism of starvation-induced ribophagyF31CA232355 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ROBERTS, JUSTIN MICHAEL · 2019 to 2022
$183k
Determining the mechanism of aspartate sensing by the mTOR pathwayF30CA210373 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI OROZCO, JOSE MIGUEL · 2016 to 2018
$147k
Genetic identification of novel mTORC1 regulators and homeostatic signaling mechanismsF31CA228241 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ADELMANN, CHARLES HANK · 2018 to 2020
$134k
Howard Hughes Medical InstituteNCI NIH HHS F30 CA210373NCI NIH HHS F31 CA228241NCI NIH HHS F31 CA232355NCI NIH HHS K00 CA234839NCI NIH HHS R01 CA103866NCI NIH HHS R01 CA129105NIAID NIH HHS R01 AI047389NIGMS NIH HHS T32 GM007287NIGMS NIH HHS T32 GM007753
6 · The paper itself

Abstract

In mammalian cells, nutrients and growth factors signal through an array of upstream proteins to regulate the mTORC1 growth control pathway. Because the full complement of these proteins has not been systematically identified, we developed a FACS-based CRISPR-Cas9 genetic screening strategy to pinpoint genes that regulate mTORC1 activity. Along with almost all known positive components of the mTORC1 pathway, we identified many genes that impact mTORC1 activity, including

Indexed as

3-Hydroxyacyl CoA DehydrogenasesActivating Transcription Factor 4Adaptor Proteins, Signal TransducingAmino AcidsAntimycin ACRISPR-Associated Protein 9CRISPR-Cas SystemsCulture MediaeIF-2 KinaseGene EditingGene Expression RegulationGenome, HumanGlucoseHEK293 CellsHumansInsulin Receptor Substrate Proteins3-Hydroxyacyl CoA DehydrogenasesActivating Transcription Factor 4Adaptor Proteins, Signal TransducingAmino AcidsantimycinAntimycin AATF4 protein, humanCCDC43 protein, humanCRISPR-Associated Protein 9Culture MediaDCAF7 protein, humanEIF2AK1 protein, humanEIF2AK4 protein, humaneIF-2 KinaseGlucoseHSD17B10 protein, humanInsulin Receptor Substrate ProteinsIRS4 protein, humanMechanistic Target of Rapamycin Complex 1Neoplasm ProteinsOligomycinsProtein Serine-Threonine KinasesRNA, Guide, CRISPR-Cas SystemsSerine-Arginine Splicing FactorsSRSF2 protein, humanCRISPR-Cas9 screenmitochondriamTORC1

Identifiers

PMID33483422
PMCPMC7848693
OpenAlexW3125525114

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.